Author

A. Galli

Primary ORCID profile (0000-0001-9023-1571 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

A. GalliiD1 paper · University of Lausanne

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Offersgaard· 1 shared J. Bukh· 1 shared J. M. Gottwein· 1 shared K. A. Gammeltoft· 1 shared L. V. Pham· 1 shared S. Feng· 1 shared S. Ramirez· 1 shared U. Fahnoe· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Offersgaard

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 in Vitro

K. A. Gammeltoft, Y. Zhou, A. Galli, A. Offersgaard, L. V. Pham, U. Fahnoe, S. Feng, S. Ramirez, J. Bukh, J. M. Gottwein

This study evaluates the efficacy of HCV protease inhibitors against SARS-CoV-2 and their interactions with remdesivir, finding simeprevir shows synergism and is the most promising for future antiviral treatments.

bioRxiv · Dec 2, 2020Microbiology